ACM
ABCL icon

Aquatic Capital Management’s AbCellera Biologics ABCL Stock Holding History

Aquatic Capital Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-141,885
Closed -$485K – 1305
2025
Q4 		$485K Sell
141,885
-17,530
-11% -$78.3K 0.01% 748
2025
Q3 		$802K Buy
+159,415
New +$703K 0.01% 738
2024
Q2 		– Sell
-18,700
Closed -$84.7K – 1168
2024
Q1 		$84.7K Buy
+18,700
New +$95.4K ﹤0.01% 951
2023
Q1 		– Sell
-60,900
Closed -$614K – 1202
2022
Q4 		$614K Buy
+60,900
New +$704K 0.04% 449

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Aquatic Capital Management's ABCL Position: Q1 2026 in Review

Aquatic Capital Management sold out of AbCellera Biologics (ABCL) in Q1 2026, closing a stake of 141,885 shares — an estimated $485K sold.

Aquatic Capital Management first reported a position in ABCL in Q4 2022 and held it in 4 quarters. The position peaked at $802K in Q3 2025. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Aquatic Capital Management reported no remaining AbCellera Biologics position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 141,885 AbCellera Biologics shares in Q1 2026, an estimated $485K.
  • Aquatic Capital Management first reported a position in AbCellera Biologics in Q4 2022 and held it in 4 quarters.
  • Aquatic Capital Management's AbCellera Biologics position peaked at $802K in Q3 2025.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.